News | Mammography Reporting Software | June 13, 2019

Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA

New introductions include automated, closed loop resolution manager with integrated pathology reporting, and web-based breast cancer risk assessment

Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA

June 13, 2019 — Ikonopedia will showcase its suite of structured breast reporting and Mammography Quality Standards Act (MQSA) management tools designed to improve reporting efficiency, and optimize facility operations at two upcoming radiology meetings. The company will be exhibiting at the Society for Imaging Informatics in Medicine (SIIM) annual meeting, June 26-28 in Aurora, Colo., and the Association for Medical Imaging Management (AHRA) annual meeting, July 21-25 in Aurora.

Ikonopedia recently introduced an automated, closed loop resolution manager with integrated pathology reporting capabilities to make sure that patient findings do not get lost in the shuffle of a busy clinic.  

To expand access to quality breast healthcare, Ikonopedia also recently introduced an integrated risk assessment tool, now available in any language. The company also provides users with the first-ever web-based version of the Tyrer-Cuzick Breast Cancer Risk Assessment Tool. Risk data is used to create alerts for the radiologist, populate the clinical section of the report and automatically update the patient letter. A high-risk patient alert identifies patients with a 20 percent or greater lifetime risk and information about the score is instantly viewable.

For more information: www.ikonopedia.com

Related Content

SmartXR uses a unique combination of hardware and AI-powered software to lighten radiographers’ workloads and provide image acquisition support.

SmartXR uses a unique combination of hardware and AI-powered software to lighten radiographers’ workloads and provide image acquisition support. 

Feature | Digital Radiography (DR) | May 04, 2021 | By Melinda Taschetta-Millane
The COVID-19 pandemic brought about an uptick in
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | May 03, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)

A 63-year-old multiple myeloma patient, with skeletal pain. New FDG avid axillary lymphadenopathy 62 days (9 weeks) after second mRNA vaccination dose. Image used with permission of the Radiological Society of North America (RSNA)

Feature | Coronavirus (COVID-19) | April 29, 2021 | By Melinda Taschetta-Millane
ACR releases 13 new topics and five revised topics to support referring physicians and other providers in making the most appropriate imaging or treatment decisions
News | Radiology Imaging | April 26, 2021
April 26, 2021 — The American College of Radiology (ACR) released an update to its...
The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

News | Breast Imaging | April 23, 2021
April 23, 2021 — The U.S.
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
April 22, 2021 — Targeted therapy in early stages of breas...